Company research
Virpax Pharmaceuticals, Inc.
CIK 1708331Updated Oct 6, 2026
SecurityVRPX · OTC · equity
Historical securities (1)
VRPX · NASDAQ · equity · closed Apr 3, 2025VRPX price & chart
Loading TradingView…
OTC:VRPX on TradingView ↗About the company
We are a preclinical-stage pharmaceutical company focused on developing novel and proprietary drug delivery systems across various pain indications in order to enhance compliance and optimize each product candidate in our pipeline. Our drug-delivery systems and drug-releasing technologies being developed are focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system (“CNS”) disorders to enhance patients’ quality of life.
In the news
No coverage from other publishers is available.
Financials
FY 2024 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2024 | Q3 2023 | Q3 2022 | Q2 2024 | Q2 2023 | Q2 2022 | Q1 2024 | Q1 2023 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 304,162Source | 13,038,387Source | 23,635,761Source | 2,590,609Source | 15,951,368Source | 29,402,442Source | 3,130,407Source | 18,493,347Source | 1,555,614Source | 9,628,345Source | 19,673,649Source | 39,572,436Source |
| Current assets: | ||||||||||||
| Assets, CurrentUSD | 304,162Source | 13,038,387Source | 23,635,761Source | 2,590,609Source | 15,951,368Source | 29,402,442Source | 3,130,407Source | 18,493,347Source | 1,555,614Source | 9,628,345Source | 19,673,649Source | 39,572,436Source |
| Prepaid Expense and Other Assets, CurrentUSD | 286,933Source | 885,394Source | 3,073,150Source | 719,880Source | 1,147,368Source | 3,341,307Source | 1,264,276Source | 1,506,430Source | 42,557Source | 486,833Source | 678,365Source | 2,730,444Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 2,355,774Source | 6,532,723Source | 4,207,865Source | 5,385,107Source | 3,646,770Source | 2,483,373Source | 4,343,791Source | 3,294,239Source | 2,469,374Source | 7,694,024Source | 3,094,590Source | 2,087,691Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 49Source | 117Source | 117Source | 28Source | 117Source | 117Source | 12Source | 117Source | 149Source | 12Source | 117Source | 117Source |
| Additional Paid in CapitalUSD | 66,169,610Source | 61,487,973Source | 60,795,293Source | 63,420,289Source | 61,292,409Source | 60,644,576Source | 61,551,163Source | 61,074,152Source | 70,697,451Source | 61,478,444Source | 60,933,569Source | 60,188,535Source |
| Retained Earnings (Accumulated Deficit)USD | -68,221,271Source | -54,982,426Source | -41,367,514Source | -66,214,815Source | -48,987,928Source | -33,725,624Source | -62,764,559Source | -45,875,161Source | -71,611,360Source | -59,544,135Source | -44,354,627Source | -22,703,907Source |
| Stockholders' Equity Attributable to ParentUSD | -2,051,612Source | 6,505,664Source | 19,427,896Source | -2,794,498Source | 12,304,598Source | 26,919,069Source | -1,213,384Source | 15,199,108Source | -913,760Source | 1,934,321Source | 16,579,059Source | 37,484,745Source |
| Liabilities and EquityUSD | 304,162Source | 13,038,387Source | 23,635,761Source | 2,590,609Source | 15,951,368Source | 29,402,442Source | 3,130,407Source | 18,493,347Source | 1,555,614Source | 9,628,345Source | 19,673,649Source | 39,572,436Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 2,355,774Source | 6,532,723Source | 4,207,865Source | 5,385,107Source | 3,646,770Source | 2,483,373Source | 4,343,791Source | 3,294,239Source | 2,469,374Source | 7,694,024Source | 3,094,590Source | 2,087,691Source |
| Preferred Stock, Value, Issued | —Source | — | — | — | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2024 | Q4 2023 | Q3 2024 | Q3 2023 | Q2 2024 | Q2 2023 | Q1 2024 | Q1 2023 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -12,067,225Source | — | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 72,719Source | 140,583Source | 134,699Source | 544,770Source | 745,034Source | 974,234Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -7,729,332Source | -2,008,367Source | -16,712,900Source | -9,853,772Source | -17,846,708Source | -14,542,592Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 453,951Source | — | 9,084,445Source | — | — | 51,329,788Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 17,229Source | 12,152,993Source | 1,870,729Source | 14,804,000Source | 1,866,131Source | 16,986,917Source | 1,513,057Source | 9,141,512Source | 18,995,284Source | 36,841,992Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | — | 362,822Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | -17,730Source | 195,564Source | 72,510Source | 218,257Source | 72,719Source | 140,583Source | 134,699Source | 544,770Source | 745,034Source | — |
| General and Administrative ExpenseUSD | — | — | 780,958Source | 4,619,519Source | 1,502,288Source | 1,948,700Source | 1,689,182Source | 415,451Source | 6,260,627Source | 10,572,181Source | 11,082,463Source | 7,186,385Source |
| InterestExpenseNonoperatingUSD | — | — | 92,748Source | 0Source | 11,002Source | — | — | — | 103,750Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,006,456Source | -5,994,498Source | -3,450,256Source | -3,112,767Source | -3,220,424Source | -1,520,534Source | -12,067,225Source | -15,189,508Source | -21,650,720Source | -12,056,063Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | 12,100,000Source | — | — | — |
| Nonoperating Income (Expense)USD | — | — | — | — | 8,126Source | 126,720Source | 82,033Source | 130,531Source | — | 500,281Source | — | — |
| Operating ExpensesUSD | — | — | 1,924,354Source | 6,115,138Source | 3,458,382Source | 3,239,487Source | 3,302,457Source | 1,651,065Source | 12,079,935Source | 15,689,789Source | 21,845,133Source | 12,025,500Source |
| Other Nonoperating Income (Expense)USD | — | — | -82,102Source | 120,640Source | — | — | — | — | 12,710Source | — | 194,413Source | -30,563Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | — | — | — | — | 2,165,913Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | 75Source | — | — | — |
income statement · annual statements
| Line item | Q4 2024 | Q4 2023 | Q3 2024 | Q3 2023 | Q2 2024 | Q2 2023 | Q1 2024 | Q1 2023 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -1,924,354Source | -6,115,138Source | -3,458,382Source | -3,239,487Source | -3,302,457Source | -1,651,065Source | -12,079,935Source | -15,689,789Source | -21,845,133Source | -12,025,500Source |
| Other Nonoperating Income (Expense)USD | — | — | -82,102Source | 120,640Source | — | — | — | — | 12,710Source | — | 194,413Source | -30,563Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | -5,994,498Source | — | -3,112,767Source | -3,220,424Source | -1,520,534Source | — | -15,189,508Source | -21,650,720Source | -12,056,063Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,006,456Source | -5,994,498Source | -3,450,256Source | -3,112,767Source | -3,220,424Source | -1,520,534Source | -12,067,225Source | -15,189,508Source | -21,650,720Source | -12,056,063Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.43Source | -5.12Source | -1.75Source | -2.66Source | -2.75Source | -1.3Source | -2.84Source | -12.97Source | -1.85Source | -1.81Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.43Source | -5.12Source | -1.75Source | -2.66Source | -2.75Source | -1.3Source | -2.84Source | -12.97Source | -1.85Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 4,657,711Source | 1,171,233Source | 1,977,093Source | 1,171,233Source | 1,171,233Source | 1,171,233Source | 4,254,403Source | 1,171,233Source | 11,712,186Source | 6,677,271Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 4,657,711Source | 1,171,233Source | 1,977,093Source | 1,171,233Source | 1,171,233Source | 1,171,233Source | 4,254,403Source | 1,171,233Source | 11,712,186Source | — |
| Interest Expense (non-operating)USD | — | — | 92,748Source | 0Source | 11,002Source | — | — | — | 103,750Source | — | — | — |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | — | 780,958Source | 4,619,519Source | 1,502,288Source | 1,948,700Source | 1,689,182Source | 415,451Source | 6,260,627Source | 10,572,181Source | 11,082,463Source | 7,186,385Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 92,822Source |
| Interest Expense, DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 92,822Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | 12,100,000Source | — | — | — |
| Nonoperating Income (Expense)USD | — | — | — | — | 8,126Source | 126,720Source | 82,033Source | 130,531Source | — | 500,281Source | — | — |
| Operating ExpensesUSD | — | — | 1,924,354Source | 6,115,138Source | 3,458,382Source | 3,239,487Source | 3,302,457Source | 1,651,065Source | 12,079,935Source | 15,689,789Source | 21,845,133Source | 12,025,500Source |
| Other General and Administrative ExpenseUSD | — | — | — | — | — | 169,794Source | — | 95,942Source | 2,000,000Source | — | 598,655Source | 915,423Source |
| Other IncomeUSD | — | — | — | 120,640Source | — | 126,720Source | — | 130,531Source | — | — | 194,413Source | — |
| Research and Development ExpenseUSD | — | — | 1,143,396Source | 1,495,619Source | 1,956,094Source | 1,290,787Source | 1,613,275Source | 1,235,614Source | 5,819,308Source | 5,117,608Source | 10,762,670Source | 4,839,115Source |
Offerings
Registration 333-285862
Registration 333-284089
- Gross proceeds
- 5999735.0
- Net proceeds
- 5849742.0
- Deal price
- 0.2
- Shares
- 29998675
- Offering price
- $0.20
- Ticker
- VRPX